A recap of UW Bioengineering's efforts in 2017-18 to empower better health care through biomedical innovation, and impact medicine, for Washington and for the world.
Associate Professor Deok-Ho Kim will contribute to research aimed at understanding the effects of microgravity, such as that experienced in outer space, on human health.
2018 Hoffman Lecture: Stuart Cooper, “50 Years of Polyurethane Biomaterials: The Search for Blood Compatibility and Biostability”
2018's Allan S. Hoffman Lecture will feature Stuart L. Cooper, Ph.D., the Distinguished College of Engineering Professor, Department of Chemical and Biomolecular Engineering at Ohio State University.
Former Giachelli lab postdoc Mary Wallingford defines new directions for obstetric cardiovascular medicine
At UW, former Giachelli Lab postdoc Mary Wallingford pursued novel research aimed at advancing knowledge of the body's least understood organ, the placenta. Now as an assistant professor at Tufts University, Dr. Wallingford pursues new directions for improving obstetric cardiovascular medicine.
UW Bioengineering Associate Professor Herbert Sauro will lead the $6.5M NIH-funded Center for Reproducible Biomedical Modeling, which aims to develop more predictive models of biological systems for research and medicine.
The New Innovator in NANOMED 2018 award, from the Institute of Electrical and Electronics Engineers (IEEE), recognizes individuals who have demonstrated exceptional early career technical advancement and innovation in the field of nano/molecular medicine and engineering.
UW Bioengineering ranked fourth among biomedical engineering programs by 2018 Global Ranking of Academic Subjects
The study, compiled by the Center for World-Class Universities of Shanghai Jiao Tong University, ranked more than 4,000 universities in 52 subjects across engineering, and the natural, life, medical and social sciences.
Suzie Pun, the Robert F. Rushmer Professor of Bioengineering, is one of 14 UW faculty elected to the Washington State Academy of Sciences in 2018. The academy’s mission is “to provide expert scientific and engineering analysis to inform public policymaking in Washington, and to increase the role and visibility of science in the state.”
Learning the language of business, with the help of UW's Buerk Center for Entrepreneurship, enabled the A-Alpha Bio team to launch their ideas from the lab to a startup company, and introduce their technology to Seattle's entrepreneurship community and beyond.
Professor Xiaohu Gao and colleagues have created a new way to target prostate tumors that overcomes past challenges of designing effective drug delivery methods. This versatile nanocarrier design should offer opportunities for the clinical translation of therapies based on intracellularly acting biologics.